Pathophysiology and Treatment of Pulmonary Arterial Hypertension-Reference-Cited by-同舟云学术

Pathophysiology and Treatment of Pulmonary Arterial Hypertension

Published:2024-01-18 Issue:2 Volume:25 Page:1166
ISSN:1422-0067
Container-title:International Journal of Molecular Sciences
language:en
Short-container-title:IJMS

Author:

Fukumoto Yoshihiro¹^ORCID

Affiliation:

1. Division of Cardiovascular Medicine, Department of Internal Medicine, Kurume University School of Medicine, Kurume 830-0011, Japan

Abstract

Pulmonary hypertension (PH) is recognized as a pathophysiological disorder encompassing a wide spectrum of clinical conditions related to various cardiovascular and respiratory diseases [...]

Publisher

MDPI AG

Link

https://www.mdpi.com/1422-0067/25/2/1166/pdf

Reference16 articles.

1. Guidelines for the Treatment of Pulmonary Hypertension (JCS 2017/JPCPHS 2017);Fukuda;Circ. J.,2019

2. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension;Humbert;Eur. Heart J.,2022

3. Pulmonary artery distensibility index is a non-invasive useful marker of pulmonary arterial hypertension progression;Fukumoto;Circ. J.,2011

4. Intensive immunosuppressive therapy improves pulmonary hemodynamics and long-term prognosis in patients with pulmonary arterial hypertension associated with connective tissue disease;Fukumoto;Circ. J.,2011

5. Histopathological examination by lung biopsy for the evaluation of operability and postoperative prognosis in patients with chronic thromboembolic pulmonary hypertension;Yamaki;Circ. J.,2014

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Plant Antioxidants: Therapeutic Potential in Cardiovascular Diseases;Compounds;2024-08-12